Perspectives on Post-COVID-19 Pulmonary Fibrosis Treatment

Perspectives on Post-COVID-19 Pulmonary Fibrosis Treatment

Pulmonary fibrosis, a critical outcome of chronic inflammatory diseases, has gained prominence in the context of post-coronavirus (post-COVID-19) complications. This review delves into the multifaceted landscape of post-COVID-19 pulmonary fibrosis, elucidating the intricate molecular mechanisms unde...

Full description

Bibliographic Details
Main Authors: Elena Cojocaru, Tudor Cojocaru, Giulia Mihaela Pînzariu, Ioana Vasiliu, Ioana Armașu, Cristian Cojocaru
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Personalized Medicine
Subjects:
pulmonary
fibrosis
post-COVID-19
treatment
antifibrotic
nintedanib
Online Access:https://www.mdpi.com/2075-4426/14/1/51

Internet

https://www.mdpi.com/2075-4426/14/1/51

Similar Items